Telaprevir in Genotype 3 HCV

Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: 40 Kd Pegylated interferon alfa 2a;   Drug: RibavirinSponsors:   Queen Mary University of London;   Janssen-Cilag Ltd.;   Barts & The London NHS Trust;   St George's Healthcare NHS Trust;   Bradford Teaching Hospitals NHS Foundation Trust;   Nottingham University Hospitals NHS TrustNot yet recruiting - verified July 2014

Source: ClinicalTrials.gov - March 12, 2014 Category: Research Source Type: clinical trials